FHLC

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +1.06
Percentage change 1.68	%

Held by: EBI

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	-6.10%	Shs Outstand		Perf Week	1.29%
Sponsor	Fidelity	ETF Type		Tags	equity	Return% 3Y	-0.18%	Total Holdings	348	Perf Month	-4.99%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	8.73%	AUM	-	Perf Quarter	-3.42%
Index	MSCI USA IMI Health Care 25/50 Index	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	-11.37%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	-4.36%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-	52W Range	60.39 - 74.48	Perf YTD	-1.98%
Dividend TTM	1.00 (1.56%)	ESG Type		Tags	-	Flows% 3M	-	52W High	-13.99%	Beta	0.72
Dividend Ex-Date	Mar 21, 2025	Dividend Type		Sector/Theme		Flows% YTD	-	52W Low	6.07%	ATR (14)	1.84
Expense	0.08%	Structure Type		Region		Flows% 1Y		RSI (14)	39.92	Volatility	5.97% 2.35%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.71	Prev Close	63.00
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	168.94K	Price	64.06
SMA20	-4.05%	SMA50	-6.27%	SMA200	-8.05%	Trades		Volume	82,243	Change	1.68%

Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.43%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 12:17PM	VHT: Strong Growth Outlook, But Still Overpriced (Seeking Alpha)
06:05AM	Loading…
06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-26-25 09:56PM	Franklin Core Plus Bond Fund Q4 2024 Commentary (SeekingAlpha)
09:40PM	Templeton Sustainable Emerging Markets Bond Fund Q4 2024 Commentary (SeekingAlpha)
08:18AM	Fidelity High Income Fund Q4 2024 Review (SeekingAlpha)
07:44AM	Fidelity Floating Rate High Income Fund Q4 2024 Review (SeekingAlpha)
07:23AM	Fidelity Capital & Income Fund Q4 2024 Review (SeekingAlpha)
06:36AM	Fidelity Tax-Free Bond Fund Q4 2024 Review (SeekingAlpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Jan-24-20 11:05AM	What Lies Ahead for Healthcare ETFs in Q4 Earnings? (Zacks)
Oct-21-19 11:00AM	What's in Store for Healthcare ETFs in Q3 Earnings? (Zacks)
03:36PM	Loading…
Sep-05-19 03:36PM	6 Best Health Care Funds for a Volatile Market (Kiplinger)
Jul-23-19 04:45AM	Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy (Zacks)
Jul-22-19 10:55AM	Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy (Zacks)
Apr-18-19 10:59AM	Can Q1 Earnings Lift Healthcare ETFs Higher? (Zacks)
Mar-05-19 12:04PM	The 7 Best Healthcare ETFs for a Sector Rebound (InvestorPlace)
Jan-24-19 10:59AM	Healthcare ETFs in Focus Ahead of Q4 Earnings (Zacks)
Dec-28-18 09:27AM	Healthcare and Value: 2 ETFs to Watch on Outsized Volume (Zacks)
Oct-02-18 03:15PM	The 7 Best ETFs of the Third Quarter (InvestorPlace)
Aug-14-18 06:00AM	Debut of Zero-Fee Funds Puts Fidelity ETFs in the Spotlight Again (InvestorPlace)
Aug-03-18 03:27PM	12 U.S. Sector ETFs to Play in Case of an Escalating Trade War (ETF Trends)
Apr-17-18 05:02PM	Tech Advances Could Help Healthcare ETFs Grow (ETF Trends)
11:49AM	7 Sector ETFs to Own Now (InvestorPlace)
Apr-03-18 02:59PM	Fidelity Trims Fees on 3 Bond ETFs (Benzinga)
Mar-12-18 03:54PM	Market Correction May Foreshadow Bullish Run for Stock ETFs (ETF Trends)
Nov-06-17 09:02AM	The 4 Most Promising ETFs for 2017 (XLF, FHLC) (Investopedia)
04:09PM	Loading…
Oct-24-17 04:09PM	What Analysts Recommend for Merck ahead of 3Q17 Earnings (Market Realist)
Sep-13-17 07:37AM	Must-Know Recent Developments for Gilead (Market Realist)
Sep-08-17 10:37AM	Inside Mercks Segment-Wise Performance in 2Q17 (Market Realist)
Aug-31-17 04:36PM	Eli Lilly & Co.s Revenues in 2Q17 (Market Realist)
Aug-29-17 04:35PM	Bristol-Myers Squibbs Oncology Products in 2Q17 (Market Realist)
10:39AM	Johnson & Johnsons Consumer Segment in 2Q17 (Market Realist)
Aug-23-17 07:37AM	How Allergans International Segment Performed in 2Q17 (Market Realist)
Aug-15-17 07:36AM	Pfizers Declining-Revenue Products in 2Q17 (Market Realist)
Aug-01-17 10:36AM	Eli Lillys Major Developments in 2Q17 (Market Realist)
07:41AM	Pfizer on the Street: Analyst Recommendations after 2Q17 (Market Realist)
Jul-26-17 06:06PM	Analysts Recommendations for Bristol-Myers Squibb in 2Q17 (Market Realist)
Jul-24-17 10:11AM	Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs (Zacks)
09:08AM	Johnson & Johnson: Medical Devices in 2Q17 (Market Realist)
Jul-19-17 11:55AM	J&J Brightens Outlook: Healthcare ETFs in Focus (Zacks)
Jul-17-17 09:07AM	Johnson & Johnsons 2Q17 Estimates: Medical Devices (Market Realist)
Jul-10-17 07:39AM	How 2Q17 Is Shaping Up for Pfizer (Market Realist)
Jul-04-17 09:08AM	Johnson & Johnsons Segment-Wise Performance in 1Q17 (Market Realist)
Jul-03-17 07:38AM	Merck & Co. Reported 1% Growth in Its 1Q17 Revenues (Market Realist)
Jun-27-17 07:38AM	Tanezumab Receives FDA Fast Track Designation (Market Realist)
Jun-20-17 03:36PM	Updates on the Adcetris and Opdivo Combination (Market Realist)
Jun-19-17 07:36AM	How Eli Lillys Taltz Performed in Clinical Trials (Market Realist)
Jun-13-17 07:36AM	Akcea Therapeutics Volanesorsen: 1Q17 Performance (Market Realist)
Jun-01-17 09:09AM	Eli Lilly & Co.s Revenues in 1Q17 (Market Realist)
May-31-17 09:08AM	How Johnson & Johnsons Consumer Segment Performed in 1Q17 (Market Realist)
May-23-17 08:14AM	A Close Look at Merck & Co.s Valuation after 1Q17 Earnings (Market Realist)
May-08-17 07:37AM	Pfizer: Understanding Growth Drivers in 1Q17 (Market Realist)
May-03-17 07:35AM	Is Eli Lilly & Co.s Valuation Higher Than Its Peers? (Market Realist)
May-01-17 10:29AM	What Do Analysts Expect from Mercks 1Q17 Earnings? (Market Realist)
Apr-24-17 10:36AM	Analyst Ratings and Recommendations for Eli Lilly (Market Realist)
10:06AM	Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? (Zacks)
Apr-20-17 03:35PM	Johnson & Johnsons 1Q17 Earnings: Changes in Its Growth Rate (Market Realist)
Apr-19-17 10:55AM	Lackluster J&J Q1 Pushes Healthcare ETFs Down (Zacks)
Apr-07-17 11:57AM	Analyzing the Performance of Eli Lilly Stock in 1Q17 (Market Realist)
Mar-17-17 09:06AM	How BMYs Virology Segment Performed in 2016 (Market Realist)
Mar-16-17 01:09PM	A Cost-Efficient Avenue to Health Care Exposure (Investopedia)
Mar-13-17 09:07AM	Johnson & Johnsons Revenue Trends (Market Realist)
Mar-10-17 08:00AM	Growth Strategy Offers Seven Trump ETFs And 'Black Swan' Protection (Investor's Business Daily)
Mar-09-17 02:56PM	Rising Rates Not Biggest Driver For Financials (ETF.com)
Mar-07-17 10:47AM	Are You In The Best Health Care ETF? GOP Moves To Replace ObamaCare (Investor's Business Daily)
Feb-28-17 10:35AM	Pfizers Recent Corporate and Pipeline Developments (Market Realist)
Feb-27-17 07:35AM	Merck & Co.s Valuation after Its 4Q16 Earnings (Market Realist)
Feb-24-17 09:06AM	Merck & Co.s Profit Margins for 4Q16 (Market Realist)
Jan-31-17 08:45AM	Quality and Healthcare: 2 ETFs to Watch on Outsized Volume
Jan-26-17 01:35PM	Changes in Johnson & Johnsons Growth Rate in 4Q16
Jan-25-17 10:20AM	What Can Investors Expect from Eli Lillys 4Q16 Earnings?
Jan-24-17 07:31AM	Why health-care stocks arent moving after President Trumps Obamacare executive order (MarketWatch)
Jan-23-17 11:01AM	Can Q4 Earnings Revitalize Healthcare ETFs?
07:36AM	What to Expect from JNJs Consumer Healthcare Segment
Jan-18-17 09:55AM	ETFs in Focus on Robust Q4 UnitedHealth Earnings
Dec-12-16 08:05AM	Johnson & Johnsons Pharmaceuticals Segment in 3Q16
Dec-02-16 10:04AM	Mercks Januvia and Janumet: An Investors Perspective
Nov-30-16 10:04AM	Understanding Pfizers Growth Contributors
Nov-29-16 03:04PM	Allergans US Specialized Therapeutics Segment in 3Q16
Nov-23-16 12:39PM	5 Top-Ranked Sector ETFs Thankful to Trump
Nov-07-16 08:07AM	Pfizers 3Q16 Earnings: An Overview
Nov-02-16 10:06AM	Could Allergans Revenues Show Growth in 3Q16?
08:04AM	Mercks 3Q16 Valuation Cheat Sheet
Oct-24-16 10:28AM	Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?
08:05AM	How Mercks Blockbuster Drugs Are Impacting Its Revenue
08:04AM	A Look at Johnson & Johnsons Consumer Segment in 3Q16
Oct-21-16 08:06AM	Johnson & Johnsons Growth Rate: How Has It Fluctuated?
Oct-19-16 10:01AM	Buy UnitedHealth ETFs on Upbeat Q3 Earnings
Oct-18-16 10:45AM	J&J Beats on Q3 Earnings: Should You Buy Healthcare ETFs?
Oct-17-16 10:04AM	Johnson & Johnsons Consumer Healthcare Segment: 3Q16 Estimates
Oct-03-16 10:06AM	Recent Corporate and R&D Progress for Merck & Co.
Sep-30-16 10:05AM	Which Products Were Key Contributors to Pfizers Revenue Growth?
Sep-13-16 02:44PM	Previewing Fidelity's Upcoming Low Volatility ETF
Aug-30-16 12:19PM	Whats Johnson & Johnsons Revenue Trend?
10:04AM	Allergans US Specialized Therapeutics Key to Future Growth
08:04AM	Understanding Allergans Revenue Stream in 2Q16

Fidelity MSCI Health Care Index ETF seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

Fidelity MSCI Health Care Index ETF

Upgrade your FINVIZ experience